BioMérieux SA, Thermo Fisher Scientific Inc, BD and others are Dominating the Market for Global Antimicrobial Susceptibility Testing Market in 2017

Global Antimicrobial Susceptibility Testing Market is expected to register a healthy CAGR in the forecast period 2018 to 2025. The new market report contains data for historic year 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.Access Full Report: https://databridgemarketresearch.com/reports/global-antimicrobial-susceptibility-testing-market/

The global antimicrobial susceptibility testing market highly concentrated to a few big players and rest to local players who cater to domestic markets only. bioMérieux SA dominated the antimicrobial susceptibility testing market accounting for a highest market share in 2017, followed by Thermo Fisher Scientific, BD,  Bio-Rad Laboratories among others.

bioMérieux SA.:

Founded in 1963 and headquartered in Marcy l’Etoile, France. bioMérieux SA. provides the in vitro diagnostic solutions for private and hospital laboratories, mainly for the diagnosis of infectious diseases. The company operates in industrial application, molecular biology, immunoassays, microbiology, other lines business segments

The company’s regional locations are Asia Pacific, Eastern Europe, Latin America, Middle East and Africa, Central Asia, South Asia, North America, and Western Europe. The subsidiary of bioMérieux SA. are bioMérieux Kenya Limited ( kenya), bioMérieux SRB ( Serbia), BioFire Diagnostics, LLC (U.S), Biomérieux Brasil S.A. (Brazil) , NORVEGE (Oslo) and among others.

• In July 2017, bioMérieux (France) announced that VITEK MS, it’s MALDI-TOF1 Mass Spectrometry System which is used for fastpathogen identification, has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the extended identification of mycobacteria, Nocardia and moulds. This will improve their technology and helps in product development.

Thermo Fisher Scientific Inc.:

Founded in 1956 and headquartered in Massachusetts, U.S. Thermo Fisher Scientific Inc. provides the accelerate life sciences research, solve complex analytical challenges, improve patient diagnostics, deliver medicines to market and increase laboratory productivity. The company operates in analytical instruments, life sciences solutions, specialty diagnostics, laboratory products & services other lines business segments.

The company’s regional locations are Asia Pacific, Europe, North America and rest of the world. The subsidiary of Thermo Fisher Scientific Inc are Dionex  (california), Patheon N.V. (Netherlands), Fisher Scientific Co LLC (U.S), FEI Company (U.S), Affymetrix (U.S), Nalge Nunc International (U.S). and among others.

BD:

Founded in 1897 and headquartered in New Jersey, U.S. The company engaged with the development, manufacture of  medical devices, laboratory equipments, diagnostic healthcare for pharmaceutical company, clinical laboratories and others. The company operates in BD medical, BD life sciences business segments.

The company’s regional locations are United States, Europe , Greater Asia  and others. The subsidiary of BD are Discovery Labware Inc.(U.S.), Nippon Becton Dickinson Co. Ltd. (Japan), Stanford University (U.S.), Cellular Research, Inc. (California), Becton Dickinson Canada Inc (Canada), , PreAnalytiX GmbH (Switzerland) and others.